Table 4.
Inflammatory markers of patients with lung cancer in omega-3 fatty acid supplementation and placebo groups.
| Characteristics |
Omega-3
(Mean ± SD) n = 29 |
Placebo
(Mean ± SD) n = 29 |
P-value* | |
|---|---|---|---|---|
| CRP* (mg/L) | Before | 2.69 ± 1.34 | 2.79 ± 1.24 | 0.769 |
| After | 1.42 ± 0.63 | 3.00 ± 1.05 | 0.001 | |
| TNFα**(pg/mL) | Before | 3.74 ± 1.69 | 3.87 ± 1.78 | 0.775 |
| After | 1.92 ± 0.65 | 4.24 ± 1.19 | 0.001 | |
| IL-6***(pg/mL) | Before | 4.27 ± 0.88 | 4.23 ± 0.93 | 0.852 |
| After | 4.15 ± 1.46 | 4.20 ± 1.48 | 0.901 |
C-reactive protein.
Tumor necrosis factor alpha.
Interleukin 6.